Chris Holland has been a SAS user since 1990. He currently works as a Biostatistics Director for Amgen and has prior experience heading up biostatistics departments for Sucampo Pharmaceuticals, MacroGenics, and Micromet. He has also worked as a statistical reviewer at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration. There he served as the technical lead for the SDTM/ADaM Pilot Project review team, which included FDA staff involved with assessing the suitability of CDISC standards for meeting the needs of medical and statistical reviewers. Holland continues to be active in the CDISC community, particularly with the ADaM team. He received an MS in Statistics from the University of Virginia, and a BS in Statistics from Virginia Polytechnic Institute and State University. He is an Accredited Professional Statistician by the American Statistical Association.
